CP-461 in the Treatment of Patients With Advanced Melanoma
NCT00060710
·
clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
35
Enrollment
INDUSTRY
Sponsor class
Conditions
Malignant Melanoma
Interventions
DRUG:
CP-461
Sponsor
Astellas Pharma Inc
Collaborators
[object Object]
[object Object]